Open menu

Nanotechnology General News

The latest news from academia, regulators
research labs and other things of interest

Posted: May 3, 2010

Joint transnational call for proposals on nanomedicine by EuroNanoMed

(Nanowerk News) Following the success of the 1st Joint Transnational Call in 2009, EuroNanoMed is launching its 2nd Joint Call for funding of transnational innovative research projects in Nanomedicine. This call will enable scientists from European and associated countries to establish collaborative research consortia spanning multiple disciplines.
The thematic priorities of the call focus on the strategic research priorities of the European technology platform “Nanomedicine":
  • Regenerative medicine
  • Diagnostics
  • Targeted delivery systems
  • Each proposal must involve a minimum of three research groups from three different countries including at least two EuroNanoMed member states participating in the 2d joint transnational call (Belgium, France, Germany, HUNGARY, Iceland, Israel, Latvia, Lithuania, Poland, Portugal, Romania, SPAIN, Sweden, Switzerland, Turkey). The maximum number of participants in a consortium is seven. Research groups from non-funding countries may participate in projects if they are able to secure their own funding. Such partners should state the source of funding for their part in the project. However, the majority of research groups in a consortium must be from EuroNanoMed funding member states/regions.
    Please note that the inclusion of a non-eligible partner in a proposal will result in the rejection of the entire proposal without further review (for a definition of eligible partners see "Information for applicants", the national/regional regulations, and contact your national contact person).
    Regardless of its size, each collaborative project consortium should have the optimal critical mass to achieve ambitious scientific & technological goals and should clearly show the specific contribution of each research consortium partner and the added value of working together. In particular, the project consortium should clearly demonstrate an added value in knowledge transfer towards either clinical (public health applications/research) or towards pharmaceutical/industrial applications (for details see text below).
    To apply to this joint transnational call, it is mandatory to have a consortium comprising group(s) from at least two out of the three following categories:
  • academia (research teams working in universities, other higher education institutions or research institutes);
  • clinical/public health research sector (research teams working in hospitals/public health and/or other health care settings and health organizations);
  • enterprise (all sizes of private companies). Participation of small and medium-size enterprises (SMEs) is encouraged.
  • Deadline for submission: June 11th 2010 at 17:00:00 (Brussels local time).
    Source: EuroNanoMed
    If you liked this article, please give it a quick review on reddit or StumbleUpon. Thanks!
    Check out these other trending stories on Nanowerk:

    Subscribe to a free copy of one of our daily
    Nanowerk Newsletter Email Digests
    with a compilation of all of the day's news.